Highly efficient superdisintegrant with rapid and uniform tablet disintegration in aqueous media.
Consistent performance across varying formulation pH and ionic strength conditions.
Low substitution degree ensures excellent compatibility with active pharmaceutical ingredients (APIs) and excipients.
Optimized particle size distribution for improved blend uniformity and flowability in direct compression processes.
Pharmaceutical-grade material manufactured under strict cGMP conditions and compliant with USP/NF, EP, and JP monographs.
Immediate-release oral solid dosage forms, including tablets and capsules.
Fast-dissolving tablets (FDTs) and orally disintegrating tablets (ODTs).
Direct compression formulations requiring high disintegration efficiency without excessive lubricant sensitivity.
Effervescent tablet systems where rapid water penetration and structural breakdown are critical.
Controlled-release matrix tablets as a secondary disintegrant to support dose dumping prevention.
| Chemical Type | Croscarmellose Sodium (Cross-linked Sodium Carboxymethylcellulose) |
| Product Form | White to off-white fine powder |
| Appearance | Free-flowing, odorless, tasteless powder |
| Primary Applications | Pharmaceutical superdisintegrant for oral solid dosage forms |
| Key Features | High swelling capacity, low substitution, pH-independent disintegration |
| Compliance | USP/NF, Ph. Eur., JP, and cGMP-compliant manufacturing |
| Microbial Limits | Meets USP <61>: Total aerobic microbial count ≤10³ CFU/g; absence of E. coli, Salmonella, and S. aureus |
| Residue on Ignition | 15–25% (as Na₂O equivalent) |
Contact With Us:
E-mail: wangxingqiang@ericwchem.com
Have a Questions? Call Us:
Add:
Building A1, Jiete Industrial Park, Huangpu District, Guangzhou City, Guangdong Province, China